Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide-Drug Conjugates: A New Hope for Cancer Management
Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7232-7232
Open Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

A novel peptide-drug conjugate for glioma-targeted drug delivery
Jianfen Zhou, Nana Meng, Linwei Lu, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 722-733
Closed Access | Times Cited: 3
Membrane-Active Peptides and Their Potential Biomedical Application
Andreea Gostaviceanu, Simona Gavrilaș, Lucian Copolovici, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2091-2091
Open Access | Times Cited: 9
Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections
Varshita Srivastava, Priya Godara, Sudip Prasad Jena, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129562-129562
Closed Access | Times Cited: 2
Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies
Yubo Wang, Lu Zhang, Chen Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 240-240
Open Access | Times Cited: 2
Peptide‐drug conjugate designated for targeted delivery to HER2‐expressing cancer cells
Amit Kumar Sharma, Rohit Sharma, Nitish Chauhan, et al.
Journal of Peptide Science (2024)
Closed Access | Times Cited: 2
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
Jamie Leckie, Toshifumi Yokota
(2024)
Open Access | Times Cited: 2
In vivo biodistribution and ototoxicity assessment of cationic liposomal-ceftriaxone via noninvasive trans-tympanic delivery in chinchilla models: Implications for otitis media therapy
Shayan Shafiee, Wenzhou Hong, Julliette Lucas, et al.
International Journal of Pediatric Otorhinolaryngology (2024) Vol. 178, pp. 111894-111894
Closed Access | Times Cited: 1
Dual FGFR-targeting and pH-activatable ruthenium–peptide conjugates for targeted therapy of breast cancer
João Franco Machado, Marco de Sá, Inês Pires, et al.
Dalton Transactions (2024) Vol. 53, Iss. 18, pp. 7682-7693
Open Access | Times Cited: 1
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
Jamie Leckie, Toshifumi Yokota
Molecules (2024) Vol. 29, Iss. 11, pp. 2658-2658
Open Access | Times Cited: 1
Optimizing Arsenic Therapy by Selectively Targeting Leukemia Cells
Judith A. Carrall, Wilford Lie, Jacob M. Lambert, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12101-12114
Closed Access | Times Cited: 4
Design, synthesis and bioactivity investigation of peptide-camptothecin conjugates as anticancer agents with a potential to overcome drug resistance
Chenyu Zhang, Zhong Hong-lan, Xiang Li, et al.
International Journal of Pharmaceutics (2023) Vol. 645, pp. 123402-123402
Closed Access | Times Cited: 4
Oxime-Linked Peptide–Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview
Gábor Mezö, Jacopo Gomena, Ivan Ranđelović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1864-1864
Open Access
Rigid linker peptides improve the stability and anti‐inflammation effect of human serum albumin and α‐melanocyte‐stimulating hormone fusion proteins
Yiyao Liu, Yang Li, Xueyan Wei, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 3
Closed Access
A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA’s Purple Book
Fuduan Chen, Hao Zhong, Ging Chan, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access
Potency of a small molecule that targets the molluscum contagiosum virus processivity factor increases when conjugated to a tripeptide
Hancheng Guan, Manunya Nuth, Richard W. Scott, et al.
Antiviral Research (2024) Vol. 226, pp. 105899-105899
Closed Access
In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy
Jacopo Gomena, Daniela Modena, Paola Cordella, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116767-116767
Open Access
More Targets and Treatments

(2024), pp. 183-251
Closed Access
Small Molecules and Peptide Ligands Directed Nano-therapeutics for Precise Oncological Phototherapy: Emphasis Towards Enhancing Chemotherapeutic Active Tumor Targeting Efficacy
Mona M. Agwa, Heba Elmotasem, Sarah A El-Lakany
Journal of Drug Delivery Science and Technology (2024), pp. 106313-106313
Closed Access
Navigating cancer therapy: Harnessing the power of peptide-drug conjugates as precision delivery vehicles
Bulbul Sagar, Sarthak Gupta, Mukesh Kumar, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117131-117131
Closed Access
Novel Cyclic Peptide–Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer
Andrii Bazylevich, Anthony R. Miller, Irina G. Tkachenko, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1613-1613
Open Access
Role of Peptides in Oral Cancer
Aparna Ramachandran, B. Saravanan, Debashish Dhar, et al.
(2024), pp. 133-147
Closed Access
Cyclic RGD-containing peptides: in silico exploration against BCL-X(L)
Abel Kolawole Oyebamiji, E. T. Akintayo, Cecilia O. Akintayo, et al.
The Ukrainian Biochemical Journal (2023) Vol. 95, Iss. 2, pp. 93-105
Open Access | Times Cited: 1
Dual FGFR-targeting and pH-activable Smart Ruthenium-Peptide Conjugates for targeted therapy of Breast Cancer
João Franco Machado, Marco de Sá, Inês Pires, et al.
(2023)
Open Access | Times Cited: 1
Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors
Jiaqi Zhou, Zhancheng Xie, Jialing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116032-116032
Closed Access | Times Cited: 1
Molecular modeling, synthesis and characterization of FOLR1 specific peptides for tumor targeting activity
Özgür Yılmaz
Organic Communications (2023), Iss. 3, pp. 166-173
Open Access

Scroll to top